Market Overview

Apple Watch: The Good And The Bad


As the April 24 release date of Apple Inc. (NASDAQ: AAPL)'s new product Apple Watch is approaching, information regarding its utility and features are becoming more and more clear.

Nilay Patel, editor in chief at The Verge, was on CNBC Thursday to discuss the good and the bad regarding Apple Watch.

Don't Need It

"I think it is very clear that the watch is at the very top of the hierarchy of needs, you like clearly don't need it," Patel said. "Some people will buy it. I think what's clear, I had it for about a week and it takes about a week to understand how to use it."

The Good And The Bad

"I think what's important about this is that Apple has really validated the market for these devices," Patel said. "So, there have been smartwatches out there. I think people will be interested to see it, to play with it, to hold it, to go to the Apple Store to try on all the different combinations, but this piece of technology right now is not quite ready."

He continued, "They have a little more work to do to make it a little bit more useful, to make it little bit faster, to really figure out a narrative thread for why you'd want to wear another computer on your wrist that you have to take care of and more importantly charge every single night."

Related Link: Apple Watch Reviews: 10 Things We Learned From The Critics

Utility Vs. Care & Time To Learn

Patel also remarked that, "What I mean to say is the amount of utility you get out of it versus the amount of care and upkeep that you need to put into it and the amount of learning about how to use it at this point is about roughly even. So if you like toys, you like it," Patel concluded.

Posted-In: Apple Watch CNBC Nilay Patel The VergeTech Media


Related Articles (AAPL)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

First Horizon to Settle Key Mortgage Matter

Barclays Is Boosting Teva's PT